Infect Agent Cancer. 2012 Jan 3;7(1):1.

mTOR inhibitors: A novel class of anti-cancer agents.

Riaz H, Riaz T, Hussain SA.

Source

Medical Student, Dow Medical College, Karachi, Pakistan. syedanashussain.91@gmail.com.

PMID:: 22214493; [PubMed - in process]
PMCID:: PMC3275452

Free PMC Article

LinkOut - more resources

Full Text Sources

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents. [Curr Cancer Drug Targets. 2004]
Review Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents.
Rao RD, Buckner JC, Sarkaria JN. Curr Cancer Drug Targets. 2004 Dec; 4(8):621-35.
The impact of mTOR inhibitors on the development of malignancy. [Transplant Proc. 2008]
The impact of mTOR inhibitors on the development of malignancy.
Geissler EK. Transplant Proc. 2008 Dec; 40(10 Suppl):S32-5.
Review Therapeutic targets: MTOR and related pathways. [Cancer Biol Ther. 2006]
Review Therapeutic targets: MTOR and related pathways.
Dancey JE. Cancer Biol Ther. 2006 Sep; 5(9):1065-73. Epub 2006 Sep 6.
Review Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. [Curr Cancer Drug Targets. 2009]
Review Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.
Morgan TM, Koreckij TD, Corey E. Curr Cancer Drug Targets. 2009 Mar; 9(2):237-49.
Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. [J Heart Lung Transplant. 2007]
Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H. J Heart Lung Transplant. 2007 Jun; 26(6):557-64.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

mTOR inhibitors: A novel class of anti-cancer agents.
mTOR inhibitors: A novel class of anti-cancer agents.
Infect Agent Cancer. 2012 Jan 3 ;7(1):1.

PubMed
T antigen is bound to a host protein in SV40-transformed cells.
T antigen is bound to a host protein in SV40-transformed cells.
Nature. 1979 Mar 15 ;278(5701):261-3.

PubMed
A population-based cross-sectional study of age-specific risk factors for high r...
A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria.
Infect Agent Cancer. 2011 Jul 29 ;6:12.

PubMed
The pathogenesis of Burkitt's lymphoma.
The pathogenesis of Burkitt's lymphoma.
Adv Cancer Res. 1990 ;55:133-270.

PubMed
HIV-associated Hodgkin lymphoma during the first months on combination antiretro...
HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.
Blood. 2011 Jul 7 ;118(1):44-9. Epub 2011 May 6 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

mTOR inhibitors: A novel class of anti-cancer agents.

Source

LinkOut - more resources

Full Text Sources

Libraries

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information